# Hematopoietic Stem Cell Therapy for Patients With Multiple Sclerosis

> **NCT00278655** · PHASE1,PHASE2 · TERMINATED · sponsor: **Northwestern University** · enrollment: 21 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **BIOLOGICAL:** Hematopoietic stem cell transplantation

## Key facts

- **NCT ID:** NCT00278655
- **Lead sponsor:** Northwestern University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2003-06
- **Primary completion:** 2011-12
- **Final completion:** 2012-05
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2014-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00278655

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00278655, "Hematopoietic Stem Cell Therapy for Patients With Multiple Sclerosis". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT00278655. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*